What Happened With Invo BioScience Stock Today?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 14 2024
0mins
Source: Benzinga
Merger Announcement: INVO BioScience, Inc. shares surged after the company announced its merger with NAYA Biosciences, which will expand its focus to oncology and autoimmune diseases while continuing its fertility business.
Leadership and Market Reaction: The combined entity will be led by Invo's current CEO and CFO, along with Dr. Daniel Teper from Naya Biosciences. Following the announcement, INVO shares rose significantly, gaining over 92% in value during the trading session.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
